Broadfin Capital, LLC

Director at BIODELIVERY SCIENCES INTERNATIONAL INC; 10% owner at Societal CDMO, Inc.; 10% owner at ARATANA THERAPEUTICS, INC., and 3 more

Sold, on record
$47.9M
Dollars the filings state
Form 4 sales
10
Latest Dec 20, 2019
Form 144 notices
0
Proposed sales
Companies
6
Filed as an executive or holder

Companies

Sales by reason

0
Routine
8
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Nov 16, 2017 2017

    Sold 60,000 shares at $18.05 ($1.1M)

    Broadfin Capital, LLC, 10% owner

    Sold 2.2% of holdings ($50.3M position)2.7M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Corium International, Inc.Plan not stated
    Nov 17, 2017 +1 day

    Sold 500,000 shares at $10.96 ($5.5M)

    Broadfin Capital, LLC, 10% owner

    Sold 12.3% of holdings ($44.6M position)3.6M shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Societal CDMO, Inc.Plan not stated
    Nov 30, 2017 +13 days

    Sold 222,616 shares at $9.58 ($2.1M)

    Broadfin Capital, LLC, 10% owner

    Sold 7.6% of holdings ($28.1M position)2.7M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not stated
    Dec 1, 2017 +1 day

    Sold 890,516 shares at $5.70 ($5.1M)

    Broadfin Capital, LLC, 10% owner

    Sold 17.2% of holdings ($29.6M position)4.3M shares leftFirst sale on recordFiling

  5. 5 Form 4 sale Societal CDMO, Inc.Plan not stated
    Mar 13, 2018 +102 days

    Sold 200,000 shares at $10.07 ($2M)

    Broadfin Capital, LLC, 10% owner

    Sold 8.2% of holdings ($24.5M position)2.2M shares leftFiling

  6. 6 Form 4 sale Societal CDMO, Inc.Plan not stated
    May 24, 2018 +72 days

    Sold 188,000 shares at $5.81 ($1.1M)

    Broadfin Capital, LLC, 10% owner

    Sold 8.4% of holdings ($13M position)2M shares leftFiling

  7. May 10, 2019 +351 days

    Sold 1.8M shares at $5.00 ($9M)

    Broadfin Capital, LLC, Director

    Sold 29.6% of holdings ($30.4M position)4.3M shares leftFirst sale on recordFiling

  8. Dec 20, 2019 +224 days

    Sold 2M shares at $6.40 ($12.8M)

    Broadfin Capital, LLC, Director

    Sold 46.5% of holdings ($27.5M position)2.3M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Broadfin Capital, LLC
Source
Dec 20, 2019Dec 20, 2019BIODELIVERY SCIENCES INTERNATIONAL INCDirectorForm 4 sale2M$12.8M46.5%UnusualSEC
May 10, 2019May 14, 2019BIODELIVERY SCIENCES INTERNATIONAL INCDirectorForm 4 sale1.8M$9M29.6%UnusualSEC
May 24, 2018May 24, 2018Societal CDMO, Inc.10% ownerForm 4 sale188,000$1.1M8.4%Plan not statedSEC
Mar 13, 2018Mar 15, 2018Societal CDMO, Inc.10% ownerForm 4 sale200,000$2M8.2%Plan not statedSEC
Dec 1, 2017Dec 1, 2017ARATANA THERAPEUTICS, INC.10% ownerForm 4 sale890,516$5.1M17.2%Plan not statedSEC
Nov 30, 2017Nov 30, 2017Societal CDMO, Inc.10% ownerForm 4 sale222,616$2.1M7.6%Plan not statedSEC
Nov 17, 2017Nov 17, 2017Corium International, Inc.10% ownerForm 4 sale500,000$5.5M12.3%Plan not statedSEC
Nov 16, 2017Nov 20, 2017Mirati Therapeutics, Inc.10% ownerForm 4 sale60,000$1.1M2.2%Plan not statedSEC
Feb 15, 2017Feb 15, 2017PROGENICS PHARMACEUTICALS INC10% ownerForm 4 sale602,600$5.8M7.9%Plan not statedSEC
Feb 9, 2017Feb 9, 2017PROGENICS PHARMACEUTICALS INC10% ownerForm 4 sale351,300$3.4M4.4%Plan not statedSEC